Yes. This is a classic case of buying on negative news. We know what it takes to move up. Everything that happens prior is noise. Once the efficacy study is reported this stock doubles. Everything follows from there. It's easy for the detractors until that study is reported.
that is a great idea buy on the down that way if it does not recover you will lose even more. Myself I am sitting and waiting for it too explode if not I keep more of my investment I like buying on the up it feels a lot better then sweating out the decline we are already down .25 in a very short period of time